At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Jun 16, 2008 patterson matthew r Officer Automatic Sell 4,900 11.12 - 11.25
Jun 17, 2008 patterson matthew r Officer Automatic Sell 1,800 11.00 - 11.20
Jun 18, 2008 patterson matthew r Officer Automatic Sell 1,500 10.95 - 11.12
Jun 19, 2008 patterson matthew r Officer Automatic Sell 400 11.02 - 11.11
Jun 20, 2008 patterson matthew r Officer Automatic Sell 1,400 11.25 - 11.54
Aug 12, 2008 schaeffer orlov s nicole Officer Automatic Sell 208 18.00
Aug 13, 2008 schaeffer orlov s nicole Officer Automatic Sell 5 18.00
Nov 4, 2009 barer sol j Director Buy 20,000 4.13
Mar 15, 2013 barer sol j Director Buy 25,000 3.40
Mar 7, 2012 barrett m james Director Buy 925,154 5.70
Mar 7, 2012 barris peter j Beneficial Owner (10% or more) Buy 1,140,000 5.70
Jun 17, 2011 crowley john f Officer Buy 20,000 6.04
Aug 11, 2011 crowley john f Officer Buy 10,000 4.20
Mar 2, 2010 crowley john f Officer Buy 11,898 3.69
Mar 4, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 4,500 9.60 - 9.84
Mar 4, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 9,000 9.85 - 10.12
Mar 3, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 43,674 9.51 - 9.82
Mar 3, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 18,426 9.83 - 10.00
Mar 5, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 12,008 9.64 - 9.75
Mar 5, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 37,992 9.76 - 10.18
Showing 181-200 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy